| scholarly article | Q13442814 |
| P50 | author | Vasilis Ntziachristos | Q59193800 |
| P2093 | author name string | Hee-Seung Bom | |
| Jung-Joon Min | |||
| Yeongjin Hong | |||
| Myung Geun Shin | |||
| Sun-Chang Kim | |||
| Hyon E Choy | |||
| Hyung-Seok Kim | |||
| Hee Jung Lee | |||
| Michael Szardenings | |||
| Seung-Hwan Park | |||
| Jin Hai Zheng | |||
| Sheng-Nan Jiang | |||
| P2860 | cites work | Combination bacteriolytic therapy for the treatment of experimental tumors | Q24555050 |
| Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter | Q27860697 | ||
| In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit | Q28222502 | ||
| In vitro and in vivo effects of doxycycline on Toxoplasma gondii | Q28335472 | ||
| Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium | Q30491729 | ||
| Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
| Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy | Q33731187 | ||
| Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium | Q33756746 | ||
| Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer | Q33925546 | ||
| Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals | Q33933869 | ||
| Regulation of bacterial drug export systems | Q34300836 | ||
| Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins | Q34301980 | ||
| Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output | Q34549716 | ||
| Posttranscriptional control of the Salmonella enterica flagellar hook protein FlgE | Q34564953 | ||
| In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines. | Q34691545 | ||
| Molecular imaging of cancer with positron emission tomography | Q34810431 | ||
| Engineering and visualization of bacteria for targeting infarcted myocardium | Q34994526 | ||
| Bacteria as tumour-targeting vectors | Q35215803 | ||
| Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer | Q35840470 | ||
| Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model | Q35859997 | ||
| Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth | Q35921725 | ||
| Tet B or not tet B: advances in tetracycline-inducible gene expression | Q35959206 | ||
| Inhibition of tumor growth using salmonella expressing Fas ligand | Q36812613 | ||
| Mouse models for tumor metastasis | Q36908430 | ||
| Engineering the perfect (bacterial) cancer therapy | Q37131536 | ||
| Biological gene delivery vehicles: beyond viral vectors | Q37412239 | ||
| Bacteriolytic therapy can generate a potent immune response against experimental tumors | Q37585498 | ||
| Production of protein complexes via co-expression | Q37778549 | ||
| Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli | Q38503600 | ||
| Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters. | Q39492726 | ||
| Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer | Q39760012 | ||
| Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice | Q39814944 | ||
| Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment | Q40022374 | ||
| Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo | Q40171422 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| Improved mycobacterial tetracycline inducible vectors | Q41236337 | ||
| Antitumor effect of Bifidobacterium infantis in mice | Q43439628 | ||
| Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice | Q43677697 | ||
| Systemic targeting of primary bone tumor and lung metastasis of high-grade osteosarcoma in nude mice with a tumor-selective strain of Salmonella typhimurium | Q45062759 | ||
| Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation | Q45879277 | ||
| Whole-body imaging of bacterial infection and antibiotic response | Q46929905 | ||
| Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 | ||
| Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo | Q47992263 | ||
| Containment of tumor-colonizing bacteria by host neutrophils | Q50062621 | ||
| Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice | Q50072406 | ||
| Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin | Q50102555 | ||
| Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors | Q50102730 | ||
| Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
| Bacteria-mediated delivery of nanoparticles and cargo into cells | Q58620700 | ||
| P433 | issue | 11 | |
| P921 | main subject | visualization | Q451553 |
| P304 | page(s) | 1985-1995 | |
| P577 | publication date | 2013-08-07 | |
| P1433 | published in | Molecular Therapy | Q15762400 |
| P1476 | title | Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent | |
| P478 | volume | 21 |
| Q40937873 | Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy |
| Q37451801 | Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium |
| Q91890842 | Bacteria-cancer interactions: bacteria-based cancer therapy |
| Q50317370 | Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella |
| Q54213329 | Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models. |
| Q92063552 | Imaging of tumor colonization by Escherichia coli using 18F-FDS PET |
| Q28543432 | Impediments to enhancement of CPT-11 anticancer activity by E. coli directed beta-glucuronidase therapy |
| Q35692461 | Isolation and Characterization of a Monobody with a Fibronectin Domain III Scaffold That Specifically Binds EphA2. |
| Q36838520 | L-Asparaginase delivered by Salmonella typhimurium suppresses solid tumors |
| Q30558192 | New paradigm for tumor theranostic methodology using bacteria-based microrobot |
| Q21559447 | Post-injury treatment with 7,8-dihydroxyflavone, a TrkB receptor agonist, protects against experimental traumatic brain injury via PI3K/Akt signaling |
| Q37392922 | Pseudomonas aeruginosa mannose-sensitive hemagglutinin inhibits proliferation and invasion via the PTEN/AKT pathway in HeLa cells |
| Q37112974 | RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy |
| Q50463465 | Rhodobacter sphaeroides, a novel tumor-targeting bacteria that emits natural near-infrared fluorescence. |
| Q36191597 | Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. |
| Q90618645 | Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy |
| Q39339432 | Salmonella-Mediated Cancer Therapy: Roles and Potential |
| Q37146297 | Suppression of pancreatic ductal adenocarcinoma growth by intratumoral delivery of attenuated Salmonella typhimurium using a dual fluorescent live tracking system |
| Q38215860 | Synthetic immunosurveillance systems: nanodevices to monitor physiological events |
| Q28069354 | Targeted Cancer Therapy Using Engineered Salmonella typhimurium |
| Q36116601 | The engineered Salmonella typhimurium inhibits tumorigenesis in advanced glioma |
| Q37225613 | Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential |
| Q37355548 | Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis |
| Q58599910 | Tumour-targeting bacteria engineered to fight cancer |
| Q57210671 | Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference |
| Q104280671 | Tweak to Treat: Reprograming Bacteria for Cancer Treatment |
| Q47587450 | Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin |
Search more.